NDC 71335-0341 – Liothyronine Sodium

Liothyronine Sodium 5 ug/1 · Tablet · Oral

Human Prescription Drug

Product NDC71335-0341

Product details

Brand name
Liothyronine Sodium
Generic name
Liothyronine Sodium
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA200295
Marketed since
December 3, 2012
Listing expires
December 31, 2026
Pharmacologic class
l-Triiodothyronine

Active ingredients

Uses, dosage, side effects and warnings for Liothyronine Sodium →

Package NDC codes (6)

Package NDCDescriptionSince
71335-0341-130 TABLET in 1 BOTTLE (71335-0341-1)Apr 24, 2018
71335-0341-290 TABLET in 1 BOTTLE (71335-0341-2)Aug 16, 2019
71335-0341-360 TABLET in 1 BOTTLE (71335-0341-3)Feb 23, 2018
71335-0341-418 TABLET in 1 BOTTLE (71335-0341-4)Feb 23, 2022
71335-0341-528 TABLET in 1 BOTTLE (71335-0341-5)Feb 23, 2022
71335-0341-6100 TABLET in 1 BOTTLE (71335-0341-6)Feb 23, 2022

Other Liothyronine Sodium products